Dr Danielle Brain

Postdoctoral Research Associate looking at the Immunocompatability of Delivery system in @Liptrott_Group @LivUniISMIB

[Inst of Systems, Molecular & Integrative Biology @LivUniISMIB]

📢NEWS📢Dr Danielle Brain has been awarded funding from the @ILN_Plus Researcher in Residence (RiR) scheme to develop a 3D subcutaneous skin model to investigate immunological interactions of medicines: https://t.co/JE5GYiENF5

[Dr Danielle Brain @brain_danielle]

#LivUniGrad

[Dr Danielle Brain @brain_danielle]

#LivUniGrad

[Dr Danielle Brain @brain_danielle]

#LivUniGrad

[Dr Danielle Brain @brain_danielle]

Thanks @z_rattray

[Dr Danielle Brain @brain_danielle]

Finally passed my PhD viva 🙌🏼🎉

[Dr Danielle Brain @brain_danielle]

@Copple_lab @LippyLiptrott @livuniHLS Thanks @Copple_lab

[Dr Danielle Brain @brain_danielle]

@daniel_f_carr @LippyLiptrott @livuniHLS Thanks @daniel_f_carr

[The Immunocompatibility Group @Liptrott_Group]

Great news, from the group; @bethjheaton and @HatelyAlex will be presenting their work at the @BritToxSoc meeting, in April, and @brain_danielle at #CLINAM2022 @LivUniISMIB @livuniHLS

[Dr Danielle Brain @brain_danielle]

@davidheatonskid 😢

[Dr Danielle Brain @brain_danielle]

@PromegaFiona The best start to the weekend!

[Fiona Henderson @DigiPathFiona]

Lumie has stopped off for a little rest @LivUni

For your chance to win the last Lumie of the week give AND a new lab timer, give @PromegaFiona or @Anon_Drea a follow and like/retweet this post.

Extra entries for guessing his location and beverage of choice ☕️ #Labmascot

[Dr Danielle Brain @brain_danielle]

@PromegaFiona @LivUni @Anon_drea Oh damn we must of just missed meeting him

[Dr Danielle Brain @brain_danielle]

@PromegaFiona @bethjheaton @Anon_drea @LivUni 🦒

[Dr Danielle Brain @brain_danielle]

@bethjheaton @Anon_drea @LivUni @PromegaFiona It would make a great Christmas tree topper for our office tree 🙊🎄🤞🏻

[Editors of Advanced Drug Delivery Reviews @ADDReditors]

ADDR in press: "Drug delivery systems as Immunomodulators for therapy of infectious disease: relevance to COVID-19"
By Neill J. Liptrott & coworkers @LippyLiptrott @LivUni
#COVID19 #inflammasome #immunomodulator
https://t.co/lsLg4aB8nT